Related Experiment Video

Updated: Mar 29, 2026

Assessment of Respiratory Function in Conscious Mice by Double-chamber Plethysmography
08:58

Assessment of Respiratory Function in Conscious Mice by Double-chamber Plethysmography

Published on: July 10, 2018

44.3K

Taming the Inflammation: The Role of Corticosteroids in Pediatric Mycoplasma Pneumonia

Maria Sole Valentino1, Costanza Pagliani1, Chiara Lovati1

  • 1Pediatric Infectious Disease Unit, Luigi Sacco Hospital, University of Milan, 20157 Milan, Italy.

Children (Basel, Switzerland)
|March 28, 2026
PubMed

Insights

Corticosteroids can improve outcomes for children with Mycoplasma pneumoniae pneumonia, especially when given early. This review summarizes evidence on their use in severe and refractory cases.

Area of Science:

  • Pediatric Pulmonology
  • Infectious Diseases
  • Pharmacology

Background:

  • Mycoplasma pneumoniae pneumonia is a common cause of community-acquired pneumonia in children.
  • Severe and refractory cases pose significant management challenges.
  • The role of corticosteroids in treating pediatric Mycoplasma pneumoniae pneumonia requires clarification.

Purpose of the Study:

  • To review and synthesize evidence on corticosteroid use for pediatric Mycoplasma pneumoniae pneumonia.
  • To evaluate efficacy and safety in various clinical presentations, including severe and refractory forms.
  • To identify factors influencing corticosteroid response.

Main Methods:

  • Narrative literature review of studies from 2000-2024.
  • Inclusion of randomized controlled trials and observational studies.
  • Focus on pediatric patients with Mycoplasma pneumoniae pneumonia.

Main Results:

  • Early corticosteroid administration (within 24-36h) improved fever resolution, reduced hospital stay, and enhanced radiological recovery.
  • High-dose or pulse therapy was effective for severe/refractory cases; inhaled corticosteroids benefited milder forms.
  • Elevated CRP, LDH, and ferritin predicted corticosteroid response. Safety profile was acceptable.

Conclusions:

  • Corticosteroids show potential as adjunctive therapy for pediatric Mycoplasma pneumoniae pneumonia, particularly in selected patients.
  • Further high-quality research is needed to optimize timing, dosage, and patient selection.
  • Evidence supports considering corticosteroids for specific pediatric Mycoplasma pneumoniae pneumonia cases.

Keywords:
Mycoplasma pneumoniaecorticosteroidspediatric pneumoniarespiratory infections

Related Concept Videos

Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids01:25

Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids

Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
2.0K
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
1.1K
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease...
37
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.7K
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
4.1K
Drugs Used in Lower Respiratory Disorders: Overview01:17

Drugs Used in Lower Respiratory Disorders: Overview

Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
1.5K